For Inventors at Georgetown
Disclosing Your Invention
Disclose Your Invention
COVID-19 Related Agreements
Main Campus Research
Office of Sponsored Research
Connect with Industry
Technologies for Licensing
Industry Collaboration Opportunities
Research and Clinical Trials
The Office of Technology Commercialization (OTC) offers 2 ways to disclose your Invention: You can download Invention Disclosure Form, fill it out, and send it via email or submit it electronically using OTC’s Database.
DOWNLOAD INVENTION DISCLOSURE FORM (IDF)
SUBMIT IDF ELECTRONICALLY
Please read the information below before submitting your Invention:
If you believe that you have an invention, it is critical that you disclose the invention to the Office immediately. In some cases, an inventor can lose the right to a patent by failing to take the necessary measures to prevent the invention from entering into the public domain. Therefore, before you present your data at a meeting, submit a manuscript, or address a seminar or symposium, fill out an invention disclosure form, obtain the appropriate signatures, and return it to the Office.
We highly encourage you to submit your disclosure online for easier input, editing, and review. OTC will review and process your invention disclosure per its normal procedures – but this format should allow for faster entry into our process.
We hope this will be the first step in granting access to the evaluation of your invention and to possible subsequent patent protection and prosecution proceedings.
- Guidelines to Inventions
- Georgetown University’s Intellectual Property Policy
- Confidential Information Acknowledgement (read the below paragraph):
When you use this website, you may be presented with information and materials of a confidential and/or proprietary nature (“Confidential Information”). The Confidential Information contained on this inventor-accessible website may include, but is not necessarily limited to, unpublished patent applications and other materials that are not available to the public. By entering this website, you agree to hold all Confidential Information in confidence and not to disclose such Confidential Information to any person or entity, without the permission of the Office of Technology Commercialization (OTC). If you have any questions regarding whether any of the information on this website is Confidential Information, please contact OTC at 202-687-7424.
Other Information for Inventors and Researchers
- Material Transfer Agreements and Confidential Disclosure Agreements – How to request an MTA or CDA
- Helpful Documents for Grant Proposals
- Memo on Patent Reform to Georgetown University Community from Claudia C. Stewart, Ph.D., Vice President of Technology Commercialization
- COVID-19 related agreements and contracts during the pandemic – How to expedite execution of COVID19 research-related agreements
- On May 7th, USPTO announced a COVID-19 Prioritized Pilot Program for micro and small entity applicants (for patent purposes, Georgetown is considered a small entity). To qualify for the new program, the claims of an application must cover a product or process that is subject to U.S. Food and Drug Administration (FDA) approval for use in the prevention and/or treatment of COVID-19. For more information see : Federal Register Notice.
- The national NIH-funded CTSA network consists of 60 centers of clinical and translational research excellence across the country (called CTSA “hubs”) that support large multi-site clinical trials, which can be implemented and completed quickly and efficiently and have the power to generate meaningful and actionable results. Resources include:
1. GHUCCTS Pilot Projects (GHUCCTS)
2. NOSIs of the National Center for Advancing Clinical and Translational Science (NCATS)
3. CTSA Trial Innovation Network (TIN)
4. COVID-19 Collaboration Platform (COVID-CP)
More information on GHUCCTS CTSA COVID-19 Research Initiatives can be found on the following link: http://www.georgetownhowardctsa.org